Avanir Pharmaceuticals (AVNR) Reports In-Line Q3 EPS
Get Alerts AVNR Hot Sheet
Join SI Premium – FREE
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Dolphin Entertainment, Inc. (DLPN) Misses Q4 EPS by 33c
- Pineapple Energy Inc. (PEGY) Misses Q4 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!